Conduct post-market surveillance of therapeutic goods
ARTG-included goods must be monitored post-market for safety + performance.
criticalcurrentongoingCriminal liability
- ARTG sponsors + manufacturers (medicines + devices + biologicals).
- Inclusion of goods in the ARTG.
- Continuous; adverse-event reports per timeframes; periodic safety updates.
- PMS plan; adverse-event register; safety updates; recall procedure.
- Civil and criminal penalties under the Therapeutic Goods Act 1989 (for example, up to 5,000 penalty units ($1.82M) for an individual and 50,000 penalty units ($18.2M) for a body corporate for supplying unregistered medical devices); ARTG cancellation
Who must comply with this? The applicability test by industry, business structure and size.
Summary
Conditions of ARTG inclusion and registration, the Therapeutic Goods Regulations 1990 and the Therapeutic Goods (Medical Devices) Regulations 2002 require sponsors to conduct post-market surveillance — adverse-event reporting, safety updates, recall when warranted. Medical-device manufacturers operate quality management systems aligned to ISO 13485 with TGA conformity assessment.
Enforced by
Source legislation
Industries
Topics
medicinespmstga
Related
- CWLTHIn-vitro diagnostic medical device classification + ARTGIVDs classified by risk (Class 1-4); ARTG inclusion required for supply.
- CWLTHMaintain controlled drugs register (Schedule 8 / 9)Pharmacies + medical practices must keep contemporaneous register of S8/S9 medicines.
- CWLTHMaintain PBS approval + claim accurately for PBS-listed medicinesPharmacy approval-to-supply under s 90 National Health Act; PBS claiming subject to compliance review.
- CWLTHComply with the Therapeutic Goods Advertising CodeAdvertising of therapeutic goods to consumers must comply with the TGA Advertising Code and prohibited representations.
Reading
Frequently asked questions
- Who must comply with post-market surveillance of therapeutic goods?
- ARTG sponsors + manufacturers (medicines + devices + biologicals).
- What triggers post-market surveillance of therapeutic goods?
- Inclusion of goods in the ARTG.
- When is post-market surveillance of therapeutic goods due?
- Continuous; adverse-event reports per timeframes; periodic safety updates.
- What is the maximum penalty for post-market surveillance of therapeutic goods?
- Civil and criminal penalties under the Therapeutic Goods Act 1989 (for example, up to 5,000 penalty units ($1.82M) for an individual and 50,000 penalty units ($18.2M) for a body corporate for supplying unregistered medical devices); ARTG cancellation
- What evidence is required for post-market surveillance of therapeutic goods?
- PMS plan; adverse-event register; safety updates; recall procedure.